Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Schmaderer

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Angiogenesis|May 3, 2024
Systemic glucocorticoids use in post-COVID-syndrome patients does not affect retinal microcirculationT Kuchler, C Schmaderer
Der Nephrologe|November 17, 2021
[Innovations in peritoneal dialysis]R Hausinger, C Schmaderer, U Heemann, et al.
Transplantation Proceedings|December 23, 2008
Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporineM Roos, S Liu, M Strobl, et al.
Journal of Human Hypertension|January 29, 2010
Interrelationship between aortic stiffness and proteinuria in chronic kidney diseaseC R Pan, M Roos, C Schmaderer, et al.
Zeitschrift Fur Rheumatologie|December 1, 2020
[Prospective monitoring of a university rheumatology outpatient clinic throughout the first wave of the COVID-19 pandemic : What lessons can be learned?]M C Braunisch, Q Bachmann, A Hammitzsch, et al.
Kidney International|July 20, 2006
Angiotensin type 1 and type 2 receptor blockade in chronic allograft nephropathyJ Lutz, K Risch, S Liu, et al.
European Journal of Applied Physiology|September 2, 2011
Modulation of dendritic cells and toll-like receptors by marathon runningThomas Nickel, I Emslander, Z Sisic, et al.
Lupus|February 5, 2020
Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflectionG Lorenz, L Schul, F Schraml, et al.
Clinical Pharmacology and Therapeutics|October 16, 2013
Identification and characterization of a defective CYP3A4 genotype in a kidney transplant patient with severely diminished tacrolimus clearanceA N Werk, S Lefeldt, H Bruckmueller, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Angiogenesis|May 3, 2024
Systemic glucocorticoids use in post-COVID-syndrome patients does not affect retinal microcirculationT Kuchler, C Schmaderer
Der Nephrologe|November 17, 2021
[Innovations in peritoneal dialysis]R Hausinger, C Schmaderer, U Heemann, et al.
Transplantation Proceedings|December 23, 2008
Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporineM Roos, S Liu, M Strobl, et al.
Journal of Human Hypertension|January 29, 2010
Interrelationship between aortic stiffness and proteinuria in chronic kidney diseaseC R Pan, M Roos, C Schmaderer, et al.
Zeitschrift Fur Rheumatologie|December 1, 2020
[Prospective monitoring of a university rheumatology outpatient clinic throughout the first wave of the COVID-19 pandemic : What lessons can be learned?]M C Braunisch, Q Bachmann, A Hammitzsch, et al.
Kidney International|July 20, 2006
Angiotensin type 1 and type 2 receptor blockade in chronic allograft nephropathyJ Lutz, K Risch, S Liu, et al.
European Journal of Applied Physiology|September 2, 2011
Modulation of dendritic cells and toll-like receptors by marathon runningThomas Nickel, I Emslander, Z Sisic, et al.
Lupus|February 5, 2020
Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflectionG Lorenz, L Schul, F Schraml, et al.
Clinical Pharmacology and Therapeutics|October 16, 2013
Identification and characterization of a defective CYP3A4 genotype in a kidney transplant patient with severely diminished tacrolimus clearanceA N Werk, S Lefeldt, H Bruckmueller, et al.
Pageof 1